Skip to main content
. 2016 Sep;138(3):e20160731. doi: 10.1542/peds.2016-0731

TABLE 1.

Baseline Characteristics Stratified by Exposure to β Blockers, Before and After PS Matching

Full Cohort Matched Cohort
β Blocker Exposed β Blocker Unexposed β Blocker Exposed β Blocker Unexposed Absolute Difference
Total 10 585 2 281 531 10 561 31 683
Age (y)
 ≤19 894 (8.5) 440 708 (19.3) 894 (8.5) 2906 (9.2) −0.7
 20–24 2921 (27.6) 938 225 (41.1) 2920 (27.7) 9088 (28.7) −1
 25–29 2787 (26.3) 527 668 (23.1) 2784 (26.4) 8505 (26.8) −0.5
 30–34 2069 (19.6) 240 599 (10.6) 2060 (19.5) 5948 (18.8) 0.7
 35–39 1400 (13.2) 107 070 (4.7) 1392 (13.2) 3882 (12.3) 0.9
 ≥40 514 (4.9) 27261 (1.2) 511 (4.8) 1354 (4.3) 0.6
Race
 White 6347 (60) 1 121 952 (49.2) 6328 (59.9) 19 374 (61.2) −1.2
 Black 2658 (25.1) 574 024 (25.2) 2654 (25.1) 8028 (25.3) −0.2
 Hispanic 746 (7.1) 296 576 (13) 746 (7.1) 2099 (6.6) 0.4
 Asian 189 (1.8) 75 534 (3.3) 188 (1.8) 445 (1.4) 0.4
 Other 395 (3.7) 147 696 (6.5) 395 (3.7) 1059 (3.3) 0.4
 Unknown 250 (2.4) 65 749 (2.9) 250 (2.4) 678 (2.1) 0.2
Medical/obstetrical conditions
 Preexisting hypertension 6309 (59.6) 76 218 (3.3) 6285 (59.5) 19 251 (60.8) −1.3
 Gestational hypertension 4022 (38) 110 315 (4.8) 4006 (37.9) 12 670 (40) −2.1
 Mild preeclampsia 2626 (24.8) 92 618 (4.1) 2615 (24.8) 8018 (25.3) −0.5
 Severe preeclampsia 2474 (23.4) 42 122 (1.9) 2464 (23.3) 6828 (21.6) 1.8
 Migraine 387 (3.7) 18 859 (0.8) 383 (3.6) 1251 (4) −0.3
 Cardiac arrhythmia 973 (9.2) 16 524 (0.7) 953 (9) 2848 (9) 0
 Ischemic heart disease 48 (0.5) 591 (0) 45 (0.4) 88 (0.3) 0.2
 Anxiety 308 (2.9) 21 456 (0.9) 304 (2.9) 912 (2.9) 0
 Congestive heart failure 279 (2.6) 3025 (0.1) 268 (2.5) 554 (1.8) 0.8
 Multiple gestation 259 (2.5) 34 670 (1.5) 258 (2.4) 761 (2.4) 0
 Preterm delivery 3107 (29.4) 263 861 (11.6) 3089 (29.3) 8573 (27.1) 2.2
 Preexisting diabetes 1466 (13.9) 85 451 (3.8) 1458 (13.8) 4063 (12.8) 1
 Gestational diabetes 2175 (20.6) 190 371 (8.3) 2161 (20.5) 6281 (19.8) 0.6

Also included in the PS model: alcohol abuse, illicit drug use, tobacco use, chronic renal disease, essential tremor, number of distinct non–β blocker prescription drugs and physician visits during baseline period, calendar year, and maternal exposure to insulin or oral hypogylcemics in the final month of pregnancy.